Ob/Gyn Updated
Your Web destination for the latest in Evidence based Obstetrics, Gynecology and Women’s health.
Showing posts with label
Merck
.
Show all posts
Showing posts with label
Merck
.
Show all posts
Friday, October 12, 2018
FDA broadens the age range of Gardasil 9 to cover individuals 27 through 45 years old
›
The US Food and Drugs Administration (FDA) extended the use of Merck’s cervical cancer vaccine Gardasil 9 to include men and women age...
Wednesday, June 13, 2018
KEYTRUDA gains FDA approval for treatment of recurrent or metastatic cervical cancer
›
The U.S. Food and Drug Administration (FDA) has approved Merck’s pembrolizumab (KEYTRUDA®), for the treatment of patients with recurrent...
2 comments:
Sunday, June 18, 2017
FDA approves first cancer treatment drug based on tumor biomarker, instead of tumor origin.
›
courtesy: Merck In an important announcement, The U.S. Food and Drug Administration (FDA) granted accelerated approval to Merck’s Key...
1 comment:
›
Home
View web version
